These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Watters TM; Kenny EF; O'Neill LA Immunol Cell Biol; 2007; 85(6):411-9. PubMed ID: 17667936 [TBL] [Abstract][Full Text] [Related]
3. The structural network of inflammation and cancer: merits and challenges. Guven Maiorov E; Keskin O; Gursoy A; Nussinov R Semin Cancer Biol; 2013 Aug; 23(4):243-51. PubMed ID: 23712403 [TBL] [Abstract][Full Text] [Related]
5. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation. Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570 [TBL] [Abstract][Full Text] [Related]
6. The interleukin-1 receptor family. Boraschi D; Tagliabue A Vitam Horm; 2006; 74():229-54. PubMed ID: 17027517 [TBL] [Abstract][Full Text] [Related]
7. Structure and function of Toll/interleukin-1 receptor/resistance protein (TIR) domains. Ve T; Williams SJ; Kobe B Apoptosis; 2015 Feb; 20(2):250-61. PubMed ID: 25451009 [TBL] [Abstract][Full Text] [Related]
9. A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88. Liu Y; Li M; Fan S; Lin Y; Lin B; Luo F; Zhang C; Chen S; Li Y; Xu A J Immunol; 2010 Sep; 185(6):3391-400. PubMed ID: 20702732 [TBL] [Abstract][Full Text] [Related]
10. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529 [TBL] [Abstract][Full Text] [Related]
12. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Dunne A; O'Neill LA Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705 [TBL] [Abstract][Full Text] [Related]
13. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391 [TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry. Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656 [TBL] [Abstract][Full Text] [Related]
15. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145 [TBL] [Abstract][Full Text] [Related]
16. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
17. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Horng T; Barton GM; Flavell RA; Medzhitov R Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442 [TBL] [Abstract][Full Text] [Related]
18. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site. Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342 [TBL] [Abstract][Full Text] [Related]
19. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88. Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567 [TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans. Frazão JB; Errante PR; Condino-Neto A Arch Immunol Ther Exp (Warsz); 2013 Dec; 61(6):427-43. PubMed ID: 24057516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]